Tags

Type your tag names separated by a space and hit enter

[Incidence of posterior subcapsular cataract progression after triamcinolone acetonide administration].
Nippon Ganka Gakkai Zasshi. 2008 Sep; 112(9):786-9.NG

Abstract

PURPOSE

To investigate the incidence of posterior subcapsular cataract after topical administration of triamcinolone acetonide.

METHODS

A retrospective, case-control study was conducted in 44 phakic eyes of 38 paients who underwent administration of triamcinolone acetonide. The mean age was 64 +/- 10.4 (39-89). Only posterior sub-Tenon injection was performed. Evaluation of posterior subcapsular cataract was performed by slit lamp microscopy, and risk factors of the posterior subcapsular cataract progression were studied.

RESULTS

Eight eyes (18%) had posterior subcapsular cataract progression in the 12 months after triamcinolone acetonide injection. Five eyes (11%) required cataract surgery. The mean time to the cataract progression was 8.8 +/- 3.7 months. There was no significant difference in the posterior cataract progression between the frequency of injection, the causes of disease, and the age (p = 0.3806, 0.6561, 0.7470).

CONCLUSION

The progression of posterior subcapsular cataract is an important complication in the long-term topical administration of triamcinolone acetonide.

Authors+Show Affiliations

Department of Ophthalmology and Visual Science, Nagoya City University Graduate School of Medical Sciences, 1-Kawasumi, Mizuho-cho, Mizuho-ku, Nagoya-shi 467-8601, Japan. yoshimura.m@hotmail.co.jpNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info available

Pub Type(s)

English Abstract
Journal Article

Language

jpn

PubMed ID

18833942

Citation

Yoshimura, Masanori, et al. "[Incidence of Posterior Subcapsular Cataract Progression After Triamcinolone Acetonide Administration]." Nippon Ganka Gakkai Zasshi, vol. 112, no. 9, 2008, pp. 786-9.
Yoshimura M, Hirano Y, Nozaki M, et al. [Incidence of posterior subcapsular cataract progression after triamcinolone acetonide administration]. Nippon Ganka Gakkai Zasshi. 2008;112(9):786-9.
Yoshimura, M., Hirano, Y., Nozaki, M., Yoshida, M., & Ogura, Y. (2008). [Incidence of posterior subcapsular cataract progression after triamcinolone acetonide administration]. Nippon Ganka Gakkai Zasshi, 112(9), 786-9.
Yoshimura M, et al. [Incidence of Posterior Subcapsular Cataract Progression After Triamcinolone Acetonide Administration]. Nippon Ganka Gakkai Zasshi. 2008;112(9):786-9. PubMed PMID: 18833942.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - [Incidence of posterior subcapsular cataract progression after triamcinolone acetonide administration]. AU - Yoshimura,Masanori, AU - Hirano,Yoshio, AU - Nozaki,Miho, AU - Yoshida,Munenori, AU - Ogura,Yuichiro, PY - 2008/10/7/pubmed PY - 2008/10/29/medline PY - 2008/10/7/entrez SP - 786 EP - 9 JF - Nippon Ganka Gakkai zasshi JO - Nippon Ganka Gakkai Zasshi VL - 112 IS - 9 N2 - PURPOSE: To investigate the incidence of posterior subcapsular cataract after topical administration of triamcinolone acetonide. METHODS: A retrospective, case-control study was conducted in 44 phakic eyes of 38 paients who underwent administration of triamcinolone acetonide. The mean age was 64 +/- 10.4 (39-89). Only posterior sub-Tenon injection was performed. Evaluation of posterior subcapsular cataract was performed by slit lamp microscopy, and risk factors of the posterior subcapsular cataract progression were studied. RESULTS: Eight eyes (18%) had posterior subcapsular cataract progression in the 12 months after triamcinolone acetonide injection. Five eyes (11%) required cataract surgery. The mean time to the cataract progression was 8.8 +/- 3.7 months. There was no significant difference in the posterior cataract progression between the frequency of injection, the causes of disease, and the age (p = 0.3806, 0.6561, 0.7470). CONCLUSION: The progression of posterior subcapsular cataract is an important complication in the long-term topical administration of triamcinolone acetonide. SN - 0029-0203 UR - https://www.unboundmedicine.com/medline/citation/18833942/[Incidence_of_posterior_subcapsular_cataract_progression_after_triamcinolone_acetonide_administration]_ L2 - http://www.medicalonline.jp/meteo_linkout.php?issn=0029-0203&volume=112&issue=9&spage=786 DB - PRIME DP - Unbound Medicine ER -